drugset / Trial / NCT02909959
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
Phase 2
Completed
48 enrolled
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this randomized controlled trial is to determine if a nutritional supplement containing broccoli sprout and seed extracts, a rich source of sulforaphane, is effective in reducing core symptoms of autism spectrum disorder (ASD). The study will also explore the safety and tolerability of a sulforaphane supplement in young men with ASD, as well as its effects on challenging neuropsychiatric symptoms that are commonly associated with ASD, such as hyperactivity, irritability, and repetitive movements.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2019-05-30
- Completion
- 2019-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sulforaphane | Small molecule | 3 unknown | Oral |
| Comparator | Sulforaphane | Small molecule | 5 unknown | Oral |
| Comparator | Sulforaphane | Small molecule | 6 unknown | Oral |
| Comparator | Sulforaphane | Small molecule | 7 unknown | Oral |
| Comparator | Sulforaphane | Small molecule | 8 unknown | Oral |